Jeffrey was Executive Vice President, Global Head of Oncology & Hematology Development at Novartis, and Vice President and Medicines Development Leader at GSK. Jeffrey Legos joined Pfizer in 2025.
Jeffrey Legos is currently
Create your alert
to follow the career of Jeffrey Legos.
Do you need to know more about Jeffrey Legos? More results.
Report an error
Update the org chart details of Jeffrey Legos.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.